Innovator Spotlight: CardiaCare CEO Amir Soltanianzadeh on Disrupting AF Therapy
From medtech founder to investor and now CEO of CardiaCare, Amir Soltanianzadeh is leading a revolution in atrial fibrillation care with a non-invasive, AI-powered neuromodulation device. With strong clinical data and a Series A raise underway, he’s advancing digital therapeutics for scalable, patient-centered care. Hear his journey—from Johns Hopkins to LSI USA ‘25—and why CardiaCare may redefine how AF is treated worldwide.
Visit us https://www.lifesciencemarketr....esearch.com/insights